NDC00182-1016-05: SULFASALAZINE TABLETS.
The SULFASALAZINE TABLETS is a the manufacturer industrial component. Key specifications include special_features: COATING FEATURE:COMPRESSION;, primary_container_type: BOTTLE, therapeutic_equivalent: GOLDLINE LABS., medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 500.000 TABLETS, active_medicament_medicinal_strength: 500.000 MILLIGRAMS SULFASALAZINE ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-218-4713, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | COATING FEATURE:COMPRESSION; |
| primary_container_type | BOTTLE |
| therapeutic_equivalent | GOLDLINE LABS. |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 500.000 TABLETS |
| active_medicament_medicinal_strength | 500.000 MILLIGRAMS SULFASALAZINE ACTIVE INGREDIENT |
| NSN | 6505-01-218-4713 |
| THERAPEUTIC EQUIVALENT | GOLDLINE LABS. |
| PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | COATING FEATURE:COMPRESSION; |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 500.000 MILLIGRAMS SULFASALAZINE ACTIVE INGREDIENT |
No substitute or cross-reference records for this part.